A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy.
Kubota
Naoshi
N
First Department of Internal Medicine, Second Department of Pathology, Tokyo Medical University.
Miyazawa
Keisuke
K
Shoji
Nahoko
N
Sumi
Masahiko
M
Nakajima
Akihiro
A
Kimura
Yukihiko
Y
Oshiro
Hisashi
H
Ebihara
Yoshiro
Y
Ohyashiki
Kazuma
K
D000368:Aged; D000753:Anemia, Refractory / Q000150:complications* / Q000628:therapy; D003676:Deferoxamine / Q000009:adverse effects; D004452:Echocardiography; D017809:Fatal Outcome; D006331:Heart Diseases / Q000000981:diagnostic imaging / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D006352:Heart Ventricles; D006801:Humans; D007501:Iron / Q000493:pharmacokinetics; D007502:Iron Chelating Agents / Q000009:adverse effects; D019190:Iron Overload / Q000150:complications; D008297:Male; D009090:Mucorales / Q000302:isolation & purification / Q000378:metabolism; D009091:Mucormycosis / Q000139:chemically induced / Q000150:complications*; D009894:Opportunistic Infections / Q000150:complications*; D012307:Risk Factors; D017262:Siderophores / Q000009:adverse effects; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D065227:Transfusion Reaction
D007502:Iron Chelating Agents; D017262:Siderophores; D007501:Iron; D003676:Deferoxamine